日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

  Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients

Liu, Z., Fusi, A., Klopocki, E., Schmittel, A., Tinhofer, I., Nonnenmacher, A., & Keilholz, U. (2011). Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients. J Transl Med, 9, 70. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21595914 http://www.translational-medicine.com/content/pdf/1479-5876-9-70.pdf.

Item is

基本情報

表示: 非表示:
資料種別: 学術論文

ファイル

表示: ファイル

関連URL

表示:

作成者

表示:
非表示:
 作成者:
Liu, Z., 著者
Fusi, A., 著者
Klopocki, E.1, 著者           
Schmittel, A., 著者
Tinhofer, I., 著者
Nonnenmacher, A., 著者
Keilholz, U., 著者
所属:
1Research Group Development & Disease (Head: Stefan Mundlos), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433557              

内容説明

表示:
非表示:
キーワード: Antigens, CD45/metabolism; Antigens, Neoplasm/metabolism; Ascites/pathology; Calibration; Cell Adhesion Molecules/metabolism; Cell Line, Tumor; Humans; Immunomagnetic Separation/*methods; Keratins/metabolism; Lymphocyte Depletion; Melanoma/blood/pathology; *Microspheres; Nanoparticles/*chemistry; Neoplasms/*blood/*pathology; Neoplastic Cells, Circulating/*pathology; Pleural Effusion/pathology; Tumor Markers, Biological/metabolism
 要旨: BACKGROUND: A limitation of positive selection strategies to enrich for circulating tumor cells (CTCs) is that there might be CTCs with insufficient expression of the surface target marker which may be missed by the procedure. We optimized a method for enrichment, subsequent detection and characterization of CTCs based on depletion of the leukocyte fraction. METHODS: The 2-step protocol was developed for processing 20 mL blood and based on red blood cell lysis followed by leukocyte depletion. The remaining material was stained with the epithelial markers EpCAM and cytokeratin (CK) 7/8 or for the melanoma marker HMW-MAA/MCSP. CTCs were detected by flow cytometry. CTCs enriched from blood of patients with carcinoma were defined as EpCAM+CK+CD45-. CTCs enriched from blood of patients with melanoma were defined as MCSP+CD45-. One-hundred-sixteen consecutive blood samples from 70 patients with metastatic carcinomas (n = 48) or metastatic melanoma (n = 22) were analyzed. RESULTS: CTCs were detected in 47 of 84 blood samples (56%) drawn from carcinoma patients, and in 17 of 32 samples (53%) from melanoma patients. CD45-EpCAM-CK+ was detected in pleural effusion specimens, as well as in peripheral blood samples of patients with NSCLC. EpCAM-CK+ cells have been successfully cultured and passaged longer than six months suggesting their neoplastic origin. This was confirmed by CGH. By defining CTCs in carcinoma patients as CD45-CK+ and/or EpCAM+, the detection rate increased to 73% (61/84). CONCLUSION: Enriching CTCs using CD45 depletion allowed for detection of epithelial cancer cells not displaying the classical phenotype. This potentially leads to a more accurate estimation of the number of CTCs. If detection of CTCs without a classical epithelial phenotype has clinical relevance need to be determined.

資料詳細

表示:
非表示:
言語:
 日付: 2011
 出版の状態: 出版
 ページ: -
 出版情報: -
 目次: -
 査読: -
 学位: -

関連イベント

表示:

訴訟

表示:

Project information

表示:

出版物 1

表示:
非表示:
出版物名: J Transl Med
種別: 学術雑誌
 著者・編者:
所属:
出版社, 出版地: -
ページ: - 巻号: 9 通巻号: - 開始・終了ページ: 70 識別子(ISBN, ISSN, DOIなど): ISSN: 1479-5876 (Electronic) 1479-5876 (Linking)